TY  - JOUR
AU  - Benito Villalvilla, Cristina
AU  - Pérez Diego, Mario
AU  - Angelina Querencias, Alba
AU  - Kisand, Kai
AU  - Rebane, Ana
AU  - Subiza, José Luis
AU  - Palomares Gracia, Óscar
PY  - 2022
DO  - 10.1016/j.jaci.2021.06.012
SN  - 0091-6749
UR  - https://hdl.handle.net/20.500.14352/71283
T2  - The Journal of Allergy and Clinical Inmunology
AB  - Allergoid–mannan conjugates are novel vaccines for allergen-specific immunotherapy being currently assayed in phase 2 clinical trials. Allergoid–mannan conjugates target dendritic cells (DCs) and generate functional forkhead box P3 (FOXP3)-positive...
LA  - eng
M2  - 212
PB  - Elsevier
KW  - Allergen-specific immunotherapy
KW  - allergoid–mannan conjugates
KW  - monocytes
KW  - tolerogenic dendritic cells
KW  - regulatory T cells
KW  - metabolism
KW  - epigenetics
TI  - Allergoid–mannan conjugates reprogram monocytes into tolerogenic dendritic cells via epigenetic and metabolic rewiring
TY  - journal article
VL  - 149
ER  -